IMPLANTABLE NEUROSTIMULATOR NEU_INS_STIMULATOR

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a health professional,literatur report with the FDA on 2019-05-31 for IMPLANTABLE NEUROSTIMULATOR NEU_INS_STIMULATOR manufactured by Medtronic Neuromodulation.

Event Text Entries

[146767759] Date of event. Please note that this date is based off the date of publication of the article as the actual event date was not provided. Other relevant device(s) are: product id: 3389, serial/lot #: unknown; product id: 3389, serial/lot #: unknown; product id: neu_unknown_ext, serial/lot #: unknown. The reported events were from the following literature article: wang y, grewal ss, middlebrooks eh, worrell ga, stead m, lundstrom bn, britton jw, wu m, van gompel jj. Targeting analysis of a novel parietal approach for deep brain stimulation of the anterior nucleus of the thalamus for epilepsy. Epilepsy research 153 (2019) 1-6 doi: 10. 1016/j. Eplepsyres. 2019. 03. 010. If information is provided in the future, a supplemental report will be issued.
Patient Sequence No: 1, Text Type: N, H10


[146767760] The following reported events were reported in literature article: 1. Patient 1: one (b)(6)-year-old male patient underwent bilateral anterior nucleus of the thalamus (ant) deep brain stimulation (dbs) for treatment of epilepsy. Nine months after implant, the patient experienced a battery site infection. This resulted in explant of the battery and lead extensions. The cause of the delayed infection was unknown, but the patient did have dental work one month prior to the infection. 2. Patient 4: one (b)(6)-year-old female patient underwent bilateral ant dbs for treatment of epilepsy. The patient experienced a fracture of the right-side lead 18 months after the implant surgery. The lead was subsequently replaced. 3. Patient 9: one (b)(6)-year-old male patient underwent bilateral ant dbs for treatment of epilepsy. The patient experienced transient left hemiparesis. After implant, the patient developed transient contralateral motor weakness lasting one week. This was attributed to a centromedian intra-laminar parafascicular complex (cmpf) lead that was placed through the motor cortex rather than related to the ant lead.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number3007566237-2019-01214
MDR Report Key8660267
Report SourceHEALTH PROFESSIONAL,LITERATUR
Date Received2019-05-31
Date of Report2019-05-31
Date of Event2019-03-19
Date Mfgr Received2019-05-03
Date Added to Maude2019-05-31
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactLISA WOODWARD CLARK
Manufacturer Street7000 CENTRAL AVENUE NE RCW215
Manufacturer CityMINNEAPOLIS MN 55432
Manufacturer CountryUS
Manufacturer Postal55432
Manufacturer Phone7635263920
Manufacturer G1MEDTRONIC NEUROMODULATION
Manufacturer Street800 53RD AVE NE
Manufacturer CityMINNEAPOLIS MN 554211200
Manufacturer CountryUS
Manufacturer Postal Code554211200
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameIMPLANTABLE NEUROSTIMULATOR
Product CodeMBX
Date Received2019-05-31
Model NumberNEU_INS_STIMULATOR
Catalog NumberNEU_INS_STIMULATOR
OperatorHEALTH PROFESSIONAL
Device AvailabilityN
Device Eval'ed by Mfgr*
Device Sequence No1
Device Event Key0
ManufacturerMEDTRONIC NEUROMODULATION
Manufacturer Address800 53RD AVE NE MINNEAPOLIS MN 554211200 US 554211200


Patients

Patient NumberTreatmentOutcomeDate
101. Required No Informationntervention 2019-05-31

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.